Advanced search
Start date
Betweenand


Merkel cell polyomavirus (MCPyV) DNA prevalence in Brazilian blood donors

Full text
Author(s):
Show less -
Zucherato, Victoria Simionatto ; da Costa, Pericles Natan Mendes ; Giovanetti, Marta ; Krause, Luciana Maria Fontanari ; Alves, Daiani Cristina Ciliao ; Moreira, Renata Maria Alencar ; Pimentel, Barbara Maciel Sidou ; Haddad, Rodrigo ; Bitencourt, Hellen Tayana ; Ciccozzi, Massimo ; Junior Alcantara, Luiz Carlos ; Kashima, Simone ; Covas, Dimas Tadeu ; Slavov, Svetoslav Nanev
Total Authors: 14
Document type: Journal article
Source: TRANSFUSION CLINIQUE ET BIOLOGIQUE; v. 30, n. 1, p. 4-pg., 2023-01-31.
Abstract

Merkel cell polyomavirus (MCPyV) is an oncogenic virus that has been etiologically linked to Merkel cell carcinoma. Low levels of MCPyV DNA have been detected in blood donors with unclear impact on trans-fusion. The prevalence of MCPyV DNA in Brazilian blood donors is unclear. Therefore, the objective of this study was to evaluate the MCPyV DNA prevalence among Brazilian blood donors. We examined the pre-sence of MCPyV DNA by real-time PCR (qPCR) in a total of 450 serum samples obtained from blood donors from three Brazilian regions (North, Central-West and South). The overall estimated MCPyV DNA preva-lence was 1.1% (CI = 95%, 0.16-2.06%). Divided by region, in North Brazil (city of Macapa, state of Amapa) and South Brazil (city of Santa Maria, state of Rio Grande do Sul), the MCPyV prevalence was the same: 1.33% (CI = 95%, range 0.0-3.14%). In Central-West Brazil (city of Brasilia), the MCPyV prevalence was 0.6% (CI = 95%, 0.0-1.96%). All MCPyV positive samples showed a high cycle threshold (median Ct = 35.5), most probably related to the low viral load. More studies are necessary to unveil the impact of this oncogenic virus on transfusion medicine and if such exists, especially in regards of its infectivity and transmission potential. (c) 2022 Societe francaise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved. (AU)

FAPESP's process: 20/13194-1 - Evaluation of the prevalence and application of next generation sequencing methods for identification of emerging viruses in the area of hemotherapy
Grantee:Victória Simionatto Zucherato
Support Opportunities: Scholarships in Brazil - Technical Training Program - Technical Training
FAPESP's process: 17/23205-8 - Evaluation of the impact of emerging and reemerging viruses in the field of hemotherapy and stem cell transplantation by multiple-research approach
Grantee:Svetoslav Nanev Slavov
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 18/15826-5 - Evaluation of the impact of emerging and reemerging viruses in the field of hemotherapy and stem-cell transplantation by multiple-research approach
Grantee:Svetoslav Nanev Slavov
Support Opportunities: Scholarships in Brazil - Young Researchers